1. Home
  2. ENVX vs NNNN Comparison

ENVX vs NNNN Comparison

Compare ENVX & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVX
  • NNNN
  • Stock Information
  • Founded
  • ENVX 2006
  • NNNN 2021
  • Country
  • ENVX United States
  • NNNN Germany
  • Employees
  • ENVX N/A
  • NNNN N/A
  • Industry
  • ENVX Industrial Machinery/Components
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • ENVX Miscellaneous
  • NNNN Health Care
  • Exchange
  • ENVX Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • ENVX 2.4B
  • NNNN 2.2B
  • IPO Year
  • ENVX N/A
  • NNNN 2025
  • Fundamental
  • Price
  • ENVX $8.12
  • NNNN $25.75
  • Analyst Decision
  • ENVX Strong Buy
  • NNNN
  • Analyst Count
  • ENVX 7
  • NNNN 0
  • Target Price
  • ENVX $17.14
  • NNNN N/A
  • AVG Volume (30 Days)
  • ENVX 7.8M
  • NNNN 38.1K
  • Earning Date
  • ENVX 11-05-2025
  • NNNN 04-28-2026
  • Dividend Yield
  • ENVX N/A
  • NNNN N/A
  • EPS Growth
  • ENVX N/A
  • NNNN N/A
  • EPS
  • ENVX N/A
  • NNNN 0.06
  • Revenue
  • ENVX $30,273,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • ENVX $44.18
  • NNNN N/A
  • Revenue Next Year
  • ENVX $212.03
  • NNNN N/A
  • P/E Ratio
  • ENVX N/A
  • NNNN $489.81
  • Revenue Growth
  • ENVX 45.98
  • NNNN 21.95
  • 52 Week Low
  • ENVX $4.61
  • NNNN $5.18
  • 52 Week High
  • ENVX $16.49
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • ENVX 32.73
  • NNNN 53.32
  • Support Level
  • ENVX $8.56
  • NNNN $12.93
  • Resistance Level
  • ENVX $9.89
  • NNNN $25.20
  • Average True Range (ATR)
  • ENVX 0.73
  • NNNN 4.40
  • MACD
  • ENVX -0.41
  • NNNN 1.31
  • Stochastic Oscillator
  • ENVX 8.45
  • NNNN 91.51

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: